CTI BioPharma Corp (CTIC) has risen 0.11% in a Week, Should You Buy?

Tuesday, June 20, 2023 03:19 PM | InvestorsObserver Analysts

Mentioned in this article

CTI BioPharma Corp (CTIC) has risen 0.11% in a Week, Should You Buy?

The 71 rating InvestorsObserver gives to CTI BioPharma Corp (CTIC) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 85 percent of stocks in the Biotechnology industry, CTIC’s 71 overall rating means the stock scores better than 71 percent of all stocks.

CTIC has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on CTIC!

See Full CTIC Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 71 means the stock is more attractive than 71 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With CTI BioPharma Corp Stock Today?

CTI BioPharma Corp (CTIC) stock has gained 0.22% while the S&P 500 is lower by -0.41% as of 3:18 PM on Tuesday, Jun 20. CTIC has risen $0.02 from the previous closing price of $9.07 on volume of 2,615,848 shares. Over the past year the S&P 500 is up 16.65% while CTIC has risen 55.65%. CTIC lost -$0.58 per share the over the last 12 months. Click Here to get the full Stock Report for CTI BioPharma Corp stock.